{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:03:48Z","timestamp":1771455828164,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00607919","type":"journal-article","created":{"date-parts":[[2004,11,24]],"date-time":"2004-11-24T18:03:03Z","timestamp":1101319383000},"page":"697-704","source":"Crossref","is-referenced-by-count":53,"title":["Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics"],"prefix":"10.1007","volume":"28","author":[{"given":"L.","family":"Groop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"W\ufffdhlin-Boll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. -H.","family":"Groop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. -J.","family":"T\ufffdtterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Melander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. -M.","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fyhrqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.1957.tb54569.x","volume":"71","author":"A Loubatieres","year":"1957","unstructured":"Loubatieres A (1957) The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1945. Ann NY Acad Sci 71: 4?11","journal-title":"Ann NY Acad Sci"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/diab.16.7.487","volume":"16","author":"GM Reaven","year":"1967","unstructured":"Reaven GM, Dray J (1967) Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity onset diabetes mellitus. Diabetes 16: 487?492","journal-title":"Diabetes"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01223280","volume":"13","author":"GM Shenfield","year":"1977","unstructured":"Shenfield GM, Logan A, Shirling D, Baird J (1977) Plasma insulin and glucose levels in maturity onset diabetes treated with chlorpropamide. Diabetologia 13: 367?371","journal-title":"Diabetologia"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archinte.1969.00300130096013","volume":"123","author":"JM Feldman","year":"1969","unstructured":"Feldman JM, Lebovitz HE (1969) Appraisal of the extra-pancreatic actions of sulfonylureas. Arch Intern Med 123: 314?322","journal-title":"Arch Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0026-0495(70)90028-4","volume":"19","author":"A Marshall","year":"1970","unstructured":"Marshall A, Gingerich RL, Wright PH (1970) Hepatic effect of sulfonylureas. Metabolism 19: 1046?1052","journal-title":"Metabolism"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9343(76)90537-4","volume":"60","author":"JM Olefsky","year":"1976","unstructured":"Olefsky JM, Reaven GM (1976) Effects of sulfonylurea therapy on insulin binding on mononuclear leucocytes of diabetic patients. Am J Med 60: 80?95","journal-title":"Am J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/276184a0","volume":"276","author":"MN Feinglos","year":"1978","unstructured":"Feinglos MN, Lebovitz HE (1978) Sulphonylureas increase the number of insulin receptors. Nature 276: 184?185","journal-title":"Nature"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/acta.0.0900451","volume":"90","author":"H Beck-Nielsen","year":"1979","unstructured":"Beck-Nielsen H, Pedersen O, Lindskov NO (1979) Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. Acta Endocrinol 90: 451?462","journal-title":"Acta Endocrinol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-45-3-601","volume":"45","author":"HE Lebovitz","year":"1977","unstructured":"Lebovitz HE, Feinglos MN, Bucholtz HK, Lebovitz FL (1977) Potentiation of insulin action: a probable mechanism for the antidiabetic action of sulfonylurea drugs. J Clin Endocrinol Metab 45: 601?604","journal-title":"J Clin Endocrinol Metab"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diab.31.4.307","volume":"31","author":"MS Greenfield","year":"1982","unstructured":"Greenfield MS, Doberne L, Rosenthal M, Schultz B, Widstr\u00f6m A, Reaven GM (1982) Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin dependent diabetes mellitus. Diabetes 31: 307?312","journal-title":"Diabetes"},{"key":"CR11","volume-title":"Diabetes","author":"W Creutzfeldt","year":"1977","unstructured":"Creutzfeldt W, Ebert R (1977) Release of gastric inhibitory polypeptide (GIP) to a test meal under normal and pathological conditions in man. In: Bajaj JS (ed) Diabetes. Excerpta Medica 63, Amsterdam"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(69)91189-1","volume":"1","author":"E Samols","year":"1969","unstructured":"Samols E, Tyler JM, Mialhe P (1969) Suppression of pancreatic glucagon release by the hypoglycemic sulphonylureas. Lancet 1: 174?176","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2337\/diab.26.4.314","volume":"26","author":"E Tsalikian","year":"1977","unstructured":"Tsalikian E, Dunphy TW, Bohannon NV, Lorenzi M, Gerich JE, Forsham PH, Kane JP, Karam JH (1977) The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal. Diabetes 26: 314?321","journal-title":"Diabetes"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198106030-00003","volume":"6","author":"L Balant","year":"1981","unstructured":"Balant L (1981) Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs. Clin Pharmacokinet 6: 215?241","journal-title":"Clin Pharmacokinet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003495-198122030-00003","volume":"22","author":"EJ Jackson","year":"1981","unstructured":"Jackson EJ, Bressler R (1981) Clinical pharmacology of sulphonylurea hypoglycaemic agents, part 1. Drugs 22: 211?245","journal-title":"Drugs"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-198122040-00003","volume":"22","author":"EJ Jackson","year":"1981","unstructured":"Jackson EJ, Bressler R (1981) Clinical pharmacology of sulphonylurea hypoglycaemic agents, part 2. Drugs 22: 295?320","journal-title":"Drugs"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00563012","volume":"18","author":"E W\u00e5hlin-Boll","year":"1980","unstructured":"W\u00e5hlin-Boll E, Melander A, Sartor G, Scherst\u00e9n B (1980) Influence of food intake of the absorption and effect of glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol 18: 279?283","journal-title":"Eur J Clin Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00542327","volume":"21","author":"G Sartor","year":"1982","unstructured":"Sartor G, Lundquist I, Melander A, Scherst\u00e9n B, W\u00e5hlin-Boll E (1982) Improved effect of glibenclamide on administration before breakfast. Eur J Clin Pharmacol 21: 403?408","journal-title":"Eur J Clin Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jcem-25-10-1375","volume":"25","author":"V Herbert","year":"1965","unstructured":"Herbert V, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol 25: 1375?1384","journal-title":"J Clin Endocrinol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01219516","volume":"12","author":"T Kuzuya","year":"1976","unstructured":"Kuzuya T, Matsuda A, Saito T, Yoshida S (1976) Human Cpeptide immunoreactivity (CPR) in blood and urine ? evaluation of a radioimmunoassay method and its clinical applications. Diabetologia 12: 511?518","journal-title":"Diabetologia"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI104357","volume":"40","author":"RH Unger","year":"1961","unstructured":"Unger RH, Eisentraut AM, McCall MS, Madison LL (1961) Glucagon antibodies and an immunoassay for glucagon. J Clin Invest 40: 1280?1289","journal-title":"J Clin Invest"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0378-4347(00)81560-1","volume":"164","author":"E W\u00e5hlin-Boll","year":"1979","unstructured":"W\u00e5hlin-Boll E, Melander A (1979) High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. J Chromatogr 164: 541?546","journal-title":"J Chromatogr"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01212550","volume":"7","author":"FP Alford","year":"1971","unstructured":"Alford FP, Martin FIP, Pearson MJ (1971) The significance of interpretation of mildly abnormal oral glucose tolerance. Diabetologia 7: 173?180","journal-title":"Diabetologia"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diab.27.7.701","volume":"27","author":"KK Gambhir","year":"1978","unstructured":"Gambhir KK, Archer JA, Bradley CJ (1978) Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701?708","journal-title":"Diabetes"},{"key":"CR25","doi-asserted-by":"crossref","unstructured":"Dixon WJ (ed) BMDP statistical software 1981. University of Berkeley, California Press, 1981","DOI":"10.2307\/2530483"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00003088-198207040-00006","volume":"7","author":"E W\u00e5hlin-Boll","year":"1982","unstructured":"W\u00e5hlin-Boll E, Alm\u00e9r L-O, Melander A (1982) Bioavailability, pharmacokinetics and effects of glipizide in Type 2 diabetics. Clin Pharmacokinet 7: 363?372","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 239","key":"CR27","first-page":"44","volume":"94","author":"L Groop","year":"1980","unstructured":"Groop L, Harno K (1980) Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics. Acta Endocrinol 94 [Suppl 239]: 44?52","journal-title":"Acta Endocrinol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI109106","volume":"62","author":"OK Faber","year":"1978","unstructured":"Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kuzuya H, Horowitz DL, Rubenstein AH, Rosing N (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62: 197?203","journal-title":"J Clin Invest"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00606421","volume":"22","author":"L-O Alm\u00e9r","year":"1982","unstructured":"Alm\u00e9r L-O, Johansson E, Melander A, W\u00e5hlin-Boll E (1982) Influence of sulfonylureas on the secretion, disposal and effect of insulin. Eur J Clin Pharmacol 22: 27?32","journal-title":"Eur J Clin Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00745132","volume":"13","author":"A Zermatten","year":"1977","unstructured":"Zermatten A, Heptner W, Delaloye B, S\u00e9chaud R, Felber J-P (1977) Extrapancreatic effects of glibenclamide: stimulation of duodenal insulin-releasing activity (DIRA) in man. Diabetologia 13: 85?88","journal-title":"Diabetologia"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/jcem-37-5-826","volume":"37","author":"J Dupr\u00e9","year":"1973","unstructured":"Dupr\u00e9 J, Ross S, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 37: 826?828","journal-title":"J Clin Endocrinol Metab"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9343(83)90654-X","volume":"74","author":"RA DeFronzo","year":"1983","unstructured":"DeFronzo RA, Ferrannini E, Koivisto V (1983) New concepts in the pathogenesis and treatment of noninsulin dependent diabetes mellitus. In: Reaven GM (ed) Proceedings of a symposium. The role of insulin resistance in the pathogenesis and treatment of noninsulin dependent diabetes. Am J Med 74: pp 52?71","journal-title":"Am J Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI110257","volume":"68","author":"BL Maloff","year":"1981","unstructured":"Maloff BL, Lockwood DH (1981) In vitro effects of a sulfonylurea on insulin action in adipoocytes. Potentation of insulinstimulated hexose transport. J Clin Invest 68: 85?90","journal-title":"J Clin Invest"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00606420","volume":"22","author":"E W\u00e5hlin-Boll","year":"1982","unstructured":"W\u00e5hlin-Boll E, Sartor G, Melander A, Scherst\u00e9n B (1982) Impaired effect of sulfonylurea following increased dosage. Eur J Clin Pharmacol 22: 21?25","journal-title":"Eur J Clin Pharmacol"},{"key":"CR35","first-page":"1016","volume":"57","author":"WS Putram","year":"1981","unstructured":"Putram WS, Andersen DK, Jores RS, Lebovitz HE (1981) Selective potentation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide. J Clin Invest 57: 1016?1023","journal-title":"J Clin Invest"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00607919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00607919\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00607919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T08:26:13Z","timestamp":1585988773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00607919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00607919"],"URL":"https:\/\/doi.org\/10.1007\/bf00607919","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}